Risklick AG

Clinical trials (CTs) are used to determine whether an experimental treatment works well. Risklick AG is tackling the problem of high clinical trial failure (90%) which impose huge financial and ethical burden to companies and volunteers.
We are utilizing artificial intelligence and machine learning on empirical data of clinical trials to proactively identify obstacles and bugs in early stage of new clinical trials and mitigate them before execution.
We developed a first-of-its-kind data driven tool to assist clinical trial designers (biopharma and medtech companies) analyze and mitigate risks of their clinical trial and optimize newly designed clinical trials’ protocol. Therefore, this cost-saving tool reduces time-to-market of drug and increases likelihood of clinical trial success.